MRNA logo

MRNA
Moderna Inc

110,438
Mkt Cap
$16.39B
Volume
153,704.00
52W High
$55.20
52W Low
$22.28
PE Ratio
-5.20
MRNA Fundamentals
Price
$42.00
Prev Close
$41.95
Open
$42.87
50D MA
$35.43
Beta
1.30
Avg. Volume
14.75M
EPS (Annual)
-$9.27
P/B
1.76
Rev/Employee
$557,931.03
$9,687.72
Loading...
Loading...
News
all
press releases
Nasdaq, S&P 500 Futures Rise Ahead Of Delayed Jobs Data: Why NVDA, WBD, HOOD, MRNA, ASTS Are On Traders' Radar Today
Retail chatter on Stocktwits shows that sentiment remains deeply bearish on SPY and QQQ.
Stocktwits·3h ago
News Placeholder
More News
News Placeholder
Moderna, Inc. (NASDAQ:MRNA) Receives Consensus Rating of "Reduce" from Analysts
Shares of Moderna, Inc. (NASDAQ:MRNA - Get Free Report) have been given a consensus recommendation of "Reduce" by the eighteen ratings firms that are covering the firm, MarketBeat.com reports. Five...
MarketBeat·5h ago
News Placeholder
Why Did Moderna Stock Tumble Nearly 10% After Hours Today?
The FDA’s CBER issued a refusal-to-file letter for Moderna’s flu vaccine mRNA-1010.
Stocktwits·10h ago
News Placeholder
Moderna says FDA refuses its application for new mRNA flu vaccine
The U.S. Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with mRNA technology...
MarketBeat·13h ago
News Placeholder
Moderna says FDA refuses to review its application for experimental flu shot
Moderna said the move is inconsistent with previous feedback from the FDA on the experimental influenza shot, called mRNA-1010...
CNBC: Business·13h ago
News Placeholder
Vertex Gears Up to Report Q4 Earnings: Is a Beat in the Cards?
VRTX is set to report Q4 results amid strong Trikafta demand. Alyftrek launches are gaining traction while investors are eyeing Casgevy and Journavx sales.
Zacks·20h ago
News Placeholder
Should You Buy Moderna Before Feb. 13?
Key PointsModerna's shares have performed well this year, driven by clinical and regulatory progress...
Nasdaq News: Markets·1d ago
News Placeholder
Moderna (MRNA) Laps the Stock Market: Here's Why
In the latest trading session, Moderna (MRNA) closed at $41.95, marking a +2.29% move from the previous day.
Zacks·2d ago
News Placeholder
Top Biotech Stocks To Add to Your Watchlist - February 9th
argenex, Vertex Pharmaceuticals, Danaher, Moderna, and Medpace are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded...
MarketBeat·2d ago
News Placeholder
Will These 5 Drug Bigwigs Surpass Q4 Earnings Forecasts?
Let's look at five pharma and biotech companies, AZN, INCY, GILD, VRTX and MRNA, which are scheduled to release their fourth-quarter 2025 results this week.
Zacks·2d ago
<
1
2
...
>

Latest MRNA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.